Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing therapy for patients with brain metastases.

Timothy Kuo1, Lawrence Recht

  • 1Department of Medical Oncology, Stanford University Medical School, Palo Alto, CA 94305, USA.

Seminars in Oncology
|June 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer-related movement disorders: A scoping review and diagnostic approach.

Neuro-oncology practice·2025
Same author

Multi-layer encrypted learning for distributed healthcare analytics.

Scientific reports·2025
Same author

Characteristics and Outcomes of Patients With IDH-Mutant Grade 2 and 3 Gliomas After Deferred or Adjuvant Radiotherapy.

Neurology·2025
Same author

High levels of ubidecarenone (oxidized CoQ<sub>10</sub>) delivered using a drug-lipid conjugate nanodispersion (BPM31510) differentially affect redox status and growth in malignant glioma versus non-tumor cells.

Scientific reports·2020
Same author

Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma.

Frontiers in oncology·2020
Same author

Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model.

PloS one·2019
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Brain metastases, the most common brain tumors, have a poor prognosis but can be stratified by risk. Aggressive treatment combining surgery or stereotactic radiosurgery with whole brain radiation therapy improves survival for good-risk patients.

Area of Science:

  • Neuro-oncology
  • Cancer Metastasis
  • Radiation Oncology

Background:

  • Brain metastases are the most frequent primary brain tumors in adults.
  • Prognosis for patients with brain metastases is generally poor.
  • Risk stratification is crucial for guiding treatment decisions.

Purpose of the Study:

  • To evaluate the efficacy of aggressive therapeutic approaches for brain metastases.
  • To determine if combining local treatment with whole brain radiation therapy improves outcomes.
  • To identify factors influencing survival and central nervous system progression.

Main Methods:

  • Patient stratification based on risk factors.
  • Combination therapy including surgery or stereotactic radiosurgery (SRS).

Related Experiment Videos

  • Concomitant or sequential whole brain radiation therapy (WBRT).

    • Main Results:

    • Aggressive treatment strategies can improve survival rates.
    • Combination therapy reduces the risk of central nervous system progression.
    • Risk stratification allows for tailored, effective treatment selection.

    Conclusions:

    • An aggressive therapeutic approach is beneficial for good-risk patients with brain metastases.
    • Combining local therapies (surgery/SRS) with WBRT enhances survival and local control.
    • Risk stratification is key to optimizing treatment and outcomes in brain metastases.